- Healing of erosive esophagitis: 20-40 mg PO qd x 4-8 wks. Max: 80 mg/day
- Maintenance of healing of erosive esophagitis: 20 mg PO qd. Max: 6 months
- Symptomatic GERD: 20 mg PO qd x 4 wks (additional 4 wks may be considered for nonresponders)
Reduction of duodenal ulcer risk (eradication of H. pylori)
- 40 mg PO qd x 10 days in combination with amoxicillin (1000 mg PO bid x 10 days and clarithromycin (500 mg PO bid x 10 days)
Gastric cancer risk reduction, NSAID associated
- 20 or 40 mg PO qd. Max: 6 months
- 40 mg PO bid; Max: 240 mg/day
Short-term treatment of symptomatic GERD
- 1-11 yrs: 10 mg PO qd; Max: 8 wks
- 12-17 yrs: 20 mg or 40 mg PO qd; Max: 8 wks
Healing of Erosive Esophagitis
- 1-11 yrs, <20 kgs: 10 mg PO qd x 8 wks
- 1-11 yrs, >20 kgs: 10 mg or 20 mg PO qd x 8 wks
- Safety is not established in children <1 yrs
- Should be taken at least 1 hr before meals
Duodenal ulcer (Non-FDA Approved)
- Children>12 yrs: 15 mg PO qd × 4 wks
Gastric ulcer and NSAID induced ulcer (Non-FDA Approved)
- Children>12 yrs: 30 mg PO qd for up to 8 wks
Hypersecretory conditions (Non-FDA Approved)
- Children>12 yrs: 60 mg PO qd; dosage may be increased up to 90 mg PO bid, where doses >120 mg/24 hrs are divided bid
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.